Annual FCF
-$37.10 M
+$15.41 M+29.35%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual free cash flow is -$37.10 million, with the most recent change of +$15.41 million (+29.35%) on December 31, 2023.
- During the last 3 years, UBX annual FCF has risen by +$41.88 million (+53.03%).
- UBX annual FCF is now -99.01% below its all-time high of -$18.64 million, reached on December 31, 2016.
Performance
UBX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$5.19 M
-$609.00 K-13.29%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly free cash flow is -$5.19 million, with the most recent change of -$609.00 thousand (-13.29%) on September 30, 2024.
- Over the past year, UBX quarterly FCF has increased by +$1.93 million (+27.12%).
- UBX quarterly FCF is now -13.29% below its all-time high of -$4.58 million, reached on June 30, 2024.
Performance
UBX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$22.54 M
+$1.93 M+7.90%
September 30, 2024
Summary
- As of February 8, 2025, UBX TTM free cash flow is -$22.54 million, with the most recent change of +$1.93 million (+7.90%) on September 30, 2024.
- Over the past year, UBX TTM FCF has increased by +$18.78 million (+45.45%).
- UBX TTM FCF is now -176.37% below its all-time high of -$8.15 million, reached on March 31, 2017.
Performance
UBX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
UBX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.4% | +27.1% | +45.5% |
| 3 y3 years | +53.0% | +56.0% | +57.1% |
| 5 y5 years | +35.9% | +56.0% | +57.1% |
UBX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.4% | -13.3% | +65.3% | at high | +57.1% |
| 5 y | 5-year | at high | +53.0% | -13.3% | +79.3% | at high | +71.5% |
| alltime | all time | -99.0% | +53.0% | -13.3% | +79.3% | -176.4% | +71.5% |
Unity Biotechnology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.19 M(+13.3%) | -$22.54 M(-7.9%) |
| Jun 2024 | - | -$4.58 M(-11.6%) | -$24.47 M(-21.0%) |
| Mar 2024 | - | -$5.18 M(-31.6%) | -$30.97 M(-16.5%) |
| Dec 2023 | -$37.10 M(-29.3%) | -$7.58 M(+6.3%) | -$37.10 M(-10.2%) |
| Sep 2023 | - | -$7.13 M(-35.7%) | -$41.31 M(-8.4%) |
| Jun 2023 | - | -$11.08 M(-2.1%) | -$45.09 M(-7.7%) |
| Mar 2023 | - | -$11.32 M(-4.0%) | -$48.85 M(-7.0%) |
| Dec 2022 | -$52.51 M(+16.0%) | -$11.79 M(+8.1%) | -$52.51 M(+14.8%) |
| Sep 2022 | - | -$10.90 M(-26.6%) | -$45.76 M(-1.6%) |
| Jun 2022 | - | -$14.85 M(-0.8%) | -$46.51 M(+3.1%) |
| Mar 2022 | - | -$14.97 M(+197.3%) | -$45.12 M(-0.3%) |
| Dec 2021 | -$45.26 M(-42.7%) | -$5.04 M(-56.8%) | -$45.26 M(-20.8%) |
| Sep 2021 | - | -$11.65 M(-13.4%) | -$57.11 M(-9.1%) |
| Jun 2021 | - | -$13.46 M(-10.9%) | -$62.81 M(-8.9%) |
| Mar 2021 | - | -$15.11 M(-10.6%) | -$68.98 M(-12.7%) |
| Dec 2020 | -$78.98 M | -$16.89 M(-2.7%) | -$78.98 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$17.36 M(-11.6%) | -$78.39 M(-0.0%) |
| Jun 2020 | - | -$19.63 M(-21.8%) | -$78.41 M(+0.1%) |
| Mar 2020 | - | -$25.11 M(+54.0%) | -$78.31 M(+5.8%) |
| Dec 2019 | -$74.01 M(+27.8%) | -$16.30 M(-6.2%) | -$74.01 M(+4.3%) |
| Sep 2019 | - | -$17.37 M(-11.0%) | -$70.96 M(+4.7%) |
| Jun 2019 | - | -$19.53 M(-6.1%) | -$67.76 M(+1.6%) |
| Mar 2019 | - | -$20.80 M(+57.0%) | -$66.71 M(+15.2%) |
| Dec 2018 | -$57.89 M(+44.5%) | -$13.25 M(-6.5%) | -$57.89 M(+2.3%) |
| Sep 2018 | - | -$14.18 M(-23.3%) | -$56.56 M(+9.0%) |
| Jun 2018 | - | -$18.47 M(+54.2%) | -$51.88 M(+18.2%) |
| Mar 2018 | - | -$11.98 M(+0.5%) | -$43.88 M(+9.6%) |
| Dec 2017 | -$40.05 M(+114.8%) | -$11.93 M(+25.5%) | -$40.05 M(+42.4%) |
| Sep 2017 | - | -$9.50 M(-9.2%) | -$28.12 M(+51.0%) |
| Jun 2017 | - | -$10.47 M(+28.4%) | -$18.62 M(+128.4%) |
| Mar 2017 | - | -$8.15 M | -$8.15 M |
| Dec 2016 | -$18.64 M | - | - |
FAQ
- What is Unity Biotechnology annual free cash flow?
- What is the all time high annual FCF for Unity Biotechnology?
- What is Unity Biotechnology annual FCF year-on-year change?
- What is Unity Biotechnology quarterly free cash flow?
- What is the all time high quarterly FCF for Unity Biotechnology?
- What is Unity Biotechnology quarterly FCF year-on-year change?
- What is Unity Biotechnology TTM free cash flow?
- What is the all time high TTM FCF for Unity Biotechnology?
- What is Unity Biotechnology TTM FCF year-on-year change?
What is Unity Biotechnology annual free cash flow?
The current annual FCF of UBX is -$37.10 M
What is the all time high annual FCF for Unity Biotechnology?
Unity Biotechnology all-time high annual free cash flow is -$18.64 M
What is Unity Biotechnology annual FCF year-on-year change?
Over the past year, UBX annual free cash flow has changed by +$15.41 M (+29.35%)
What is Unity Biotechnology quarterly free cash flow?
The current quarterly FCF of UBX is -$5.19 M
What is the all time high quarterly FCF for Unity Biotechnology?
Unity Biotechnology all-time high quarterly free cash flow is -$4.58 M
What is Unity Biotechnology quarterly FCF year-on-year change?
Over the past year, UBX quarterly free cash flow has changed by +$1.93 M (+27.12%)
What is Unity Biotechnology TTM free cash flow?
The current TTM FCF of UBX is -$22.54 M
What is the all time high TTM FCF for Unity Biotechnology?
Unity Biotechnology all-time high TTM free cash flow is -$8.15 M
What is Unity Biotechnology TTM FCF year-on-year change?
Over the past year, UBX TTM free cash flow has changed by +$18.78 M (+45.45%)